US-based medical technology company Thermo Fisher Scientific has rolled out Diomni Enterprise Software to address challenges related to manual molecular testing workflows.

Diomni is designed to connect the workflow steps within a unified interface to simplify routine diagnostics testing for standardisation and faster time-to-results.

Developers and laboratories performing routine quantitative polymerase chain reaction (qPCR) diagnostic tests can use the software to rapidly develop emerging testing solutions.

Diomni Enterprise supports different types of testing workflows, including research-use-only and in-vitro diagnostic assays and instruments, said Thermo Fisher.

Thermo Fisher Scientific vice president and qPCR instruments general manager Fernando Beils said: “During the pandemic, we worked to quickly launch a digital solution that would allow clinical labs to continue operations, taking into account the dramatic changes in the PCR testing landscape.

“What followed was the earliest stages of the Diomni solution, delivering a digital platform that supports testing workflows with the flexibility required to accommodate rapidly evolving needs.

“We have continued to build on this platform and are excited to deliver a more robust and scalable tool for labs and assay developers across testing environments.”

According to the company, molecular diagnostics labs and test kit manufacturers often suffer from outdated systems that are hard for enhancing throughput or expanding the test menu.

Also, manual and inefficient steps make it difficult to track samples and maintain compliance, which is crucial for a molecular diagnostics laboratory.

Thermo Fisher said that its Diomni Enterprise Software easily connects the individual steps of the workflow in a single, unified platform to improve the productivity of qPCR workflows.

It enables the labs to operate at the highest potential by automating the interface with existing laboratory information systems (LIS) for enhanced efficiency and traceability.

By uniting labs with instruments, assays, and LIS on a single system, Diomni can increase traceability to track samples and reagents throughout the sample journey.

Also, it allows multiple individual users to access assay templates and results at the same time, said the medical technology company.